Functioning and quality of life in the Treatment for Adolescents with Depression Study (TADS)

Journal of the American Academy of Child and Adolescent Psychiatry

Volumn 45, Issue 12, 2006, Pages 1419-1426

  Vitiello, Benedetto ^b   Rohde, Paul ^j   Silva, Susan ^a,k   Wells, Karen ^a   Casat, Charles ^c,l,m   Waslick, Bruce ^e   Simons, Anne ^j   Reinecke, Mark ^h   Weller, Elizabeth ^d,n   Kratochvil, Christopher ^g,o,p   Walkup, John ^f,k   Pathak, Sanjeev ^i,k   Robins, Michele ^d   March, John ^a  

^a Coordinating Center ^*

^b NATIONAL INSTITUTE OF MENTAL HEALTH   (United States)

^c CAROLINAS MEDICAL CENTER   (United States)

^d CHILDREN S HOSPITAL OF PHILADELPHIA   (United States)

^e Och Spine at New York Presbyterian Hospitals   (United States)

^f JOHNS HOPKINS UNIVERSITY   (United States)

^g UNIVERSITY OF NEBRASKA LINCOLN   (United States)

^h NORTHWESTERN UNIVERSITY   (United States)

ⁱ UNIVERSITY OF CINCINNATI   (United States)

^j UNIVERSITY OF OREGON   (United States)

^k PFIZER

^l GLAXOSMITHKLINE   (United States)

^m GLAXOSMITHKLINE   (United Kingdom)

ⁿ ASTRAZENECA   (United Kingdom)

^o PFIZER INC   (United States)

^p Eli Lilly ^*

more..

Author keywords

Depression; Functioning; Impairment; Treatment

Indexed keywords

FLUOXETINE; PLACEBO;

ADOLESCENT; ADOLESCENT DISEASE; ARTICLE; BEHAVIOR THERAPY; CHILD DEPRESSION RATING SCALE REVISED; CHILD HEALTH; CHILD PSYCHIATRY; CHILDREN GLOBAL ASSESSMENT SCALE; CLINICAL TRIAL; COGNITIVE THERAPY; COMPARATIVE STUDY; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; FUNCTIONAL ASSESSMENT; HEALTH OF THE NATION OUTCOME SCALES FOR CHILDREN AND ADOLESCENTS; HEALTH STATUS; HUMAN; MAJOR CLINICAL STUDY; MAJOR DEPRESSION; MONOTHERAPY; MULTICENTER STUDY; PEDIATRIC QUALITY OF LIFE ENJOYMENT AND SATISFACTION QUESTIONNAIRE; PRIORITY JOURNAL; QUALITY OF LIFE; RANDOMIZED CONTROLLED TRIAL; RATING SCALE; SCORING SYSTEM; SYMPTOM; TREATMENT DURATION;

ADOLESCENT; COGNITIVE THERAPY; COMBINED MODALITY THERAPY; DEPRESSIVE DISORDER, MAJOR; DIAGNOSTIC AND STATISTICAL MANUAL OF MENTAL DISORDERS; FLUOXETINE; HUMANS; QUALITY OF LIFE; QUESTIONNAIRES; SEROTONIN UPTAKE INHIBITORS; SEVERITY OF ILLNESS INDEX;

EID: 33845410571     PISSN: 08908567     EISSN: None     Source Type: Journal    
DOI: 10.1097/01.chi.0000242229.52646.6e     Document Type: Article

References (27)

1. American Psychiatric Association (1994), Diagnostic and Statistical Manual of Mental Disorders, 4th edition (DSM-IV). Washington, DC: American Psychiatric Association
2. Bilenberg N (2003), Health of the Nation Outcome Scales for Children and Adolescents (HoNOSCA) - results of a Danish field trial. Eur Child Adolesc Psychiatry 12:298-302
3. Bird HR, Yager TJ, Staghezza B, Gould MS, Canino G, Rubio-Stipec M (1990), Impairment in the epidemiological measurement of childhood psychopathology in the community. J Am Acad Child Adolesc Psychiatry 29:796-803
4. Birmaher B, Bridge JA, Williamson DE et al. (2004), Psychosocial functioning in youths at high risk to develop major depressive disorder. J Am Acad Child Adolesc Psychiatry 43:839-846
5. Bishop SL, Walling DP, Dott SG, Folkes CC, Bucy J (1999), Refining quality of life: validating a multidimensional factor measure in the severe mentally ill. Qual Life Res 8:151-160
6. Brent DA, Holder D, Kolko D et al. (1997), A clinical psychotherapy trial for adolescent depression comparing cognitive, family, and supportive therapy. Arch Gen Psychiatry 54:877-885
7. Emslie GJ, Heiligenstein JH, Wagner KD et al. (2002), Fluoxetine for acute treatment of depression in children and adolescents: a placebo-controlled, randomized clinical trial. J Am Acad Child Adolesc Psychiatry 41:1205-1215
8. Endicott J, Nee J, Harrison W, Blumenthal R (1993), Quality of Life Enjoyment and Satisfaction Questionnaire: a new measure. Psychopharmacol Bull 29:321-326
9. Endicott J, Nee J, Yang R, Wohlberg C (2006), The Pediatric Quality of Life Enjoyment and Satisfaction Questionnaire (PQ-LES-Q): reliability and validity. J Am Acad Child Adolesc Psychiatry 45:401-407
10. Garralda ME, Yates P, Higginson I (2000), Child and adolescent mental health service use. HoNOSCA as an outcome measure. Br J Psychiatry 177:52-58
11. Gowers SG, Harrington RC, Whitton A et al. (1999), Brief scale for measuring the outcomes of emotional and behavioural disorders in children. Health of the Nation Outcome Scales for children and Adolescents (HoNOSCA). Br J Psychiatry 174:413-416
12. Hirschfeld RM, Dunner DL, Keitner G et al. (2002), Does psychosocial functioning improve independent of depressive symptoms? A comparison of nefazodone, psychotherapy and their combination. Biol Psychiatry 51:123-133
13. Keller MB, Ryan ND, Birmaher B et al. (2001), Efficacy of paroxetine in the treatment of adolescent major depression: a randomized controlled trial. J Am Acad Child Adolesc Psychiatry 40:762-772
14. Kocsis JH, Schatzberg A, Rush AJ et al. (2002), Psychosocial outcomes following long-term, double-blind treatment of chronic depression with sertraline vs placebo. Arch Gen Psychiatry 59:723-728
15. Kraemer HC, Wilson CT, Fairburn CG, Agras WS (2002), Mediators and moderators of treatment effects in randomized clinical trials. Arch Gen Psychiatry 59:877-883
16. March J, Silva S, Vitiello B (2006), The Treatment for Adolescents With Depression Study (TADS): methods and message at 12 weeks. J Am Acad Child Adolesc Psychiatry 45:1393-1403
17. Mufson L, Dorta KP, Wickramaratne P, Nomura Y, Olfson M, Weissman MM (2004), A randomized effectiveness trial of interpersonal psychotherapy for depressed adolescents. Arch Gen Psychiatry 61:577-584
18. Mufson L, Weissman MM, Moreau D, Garfinkel R (1999), Efficacy of interpersonal psychotherapy for depressed adolescents. Arch Gen Psychiatry 56:573-579
19. Papakostas GI, Petersen T, Denninger JW et al. (2004), Psychosocial functioning during the treatment of major depressive disorder with fluoxetine. J Clin Psychopharmacol 24:507-511
20. Poznanski EO, Mokros HB (1996), Manual for the Children's Depression Rating Scale-Revised. Los Angeles: Western Psychological Services
21. Puig-Antich J, Kaufman J, Ryan ND et al. (1993), The psychosocial functioning and family environment of depressed adolescents. J Am Acad Child Adolesc Psychiatry 32:244-253
22. Shaffer D, Gould MS, Brasic J et al. (1983), A Children's Global Assessment Scale (CGAS). Arch Gen Psychiatry 40:1228-1231
23. Stahl SM (2000), Placebo-controlled comparison of the selective serotonin reuptake inhibitors citalopram and sertraline. Biol Psychiatry 48:894-901
24. TADS (2003), Treatment for Adolescents with Depression Study (TADS): rationale, design, and methods. J Am Acad Child Adolesc Psychiatry 42:531-542
25. TADS (2004), The Treatment for Adolescents with Depression Study (TADS): short-term effectiveness and safety outcomes. JAMA 292:807-820
26. TADS (2005), The Treatment for Adolescents with Depression Study (TADS): demographics and clinical characteristics. J Am Acad Child Adolesc Psychiatry 44:28-40
27. Wagner KD, Ambrosini P, Rynn M et al. (2003), Efficacy of sertraline in the treatment of children and adolescents with major depressive disorder: two randomized controlled trials. JAMA 290:1033-1041